YL1004 is a SARS-CoV-2 papain-like protease inhibitor with immunomodulatory and antiviral activity in mice

Journal:

Nature Communications

Published:

2026-01-26

DOI:

10.1038/s41467-026-68795-5

Affiliations:

4

Authors:

22

Go to article

Institutions	Authors	Share
West China School of Medicine/West China Hospital of Sichuan University (WCSM/WCH), SCU, China	15.000000 15.000000	0.68
State Key Laboratory of Emerging Infectious Diseases, HKU, China	6.500000	0.30
Centre for Virology, Vaccinology and Therapeutics, China	0.500000	0.02

Interested in Medical Microbiology?